Properties (65)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
chemical compound
|
| gptkbp:advertising |
targeting healthcare providers
|
| gptkbp:built |
formulation stability
|
| gptkbp:campusFacilities |
gptkb:XYZ_University
|
| gptkbp:category |
antibiotic
|
| gptkbp:chemicalFormula |
stable under normal conditions
reacts with acids amide aryl amides contains a phenyl ring C12H15N3O2 |
| gptkbp:clinicalTrials |
ongoing
Phase II promising results |
| gptkbp:collaborations |
gptkb:ABC_Pharmaceuticals
international partnerships |
| gptkbp:community_service |
infection resolution
|
| gptkbp:compatibleWith |
antimicrobial
|
| gptkbp:competitors |
high
WPC-1176 |
| gptkbp:composedOf |
via acylation reaction
|
| gptkbp:contraindication |
headache
|
| gptkbp:dissolved |
soluble in water
|
| gptkbp:dosageForm |
tablet
|
| gptkbp:drugInterdiction |
bactericidal activity
well absorbed |
| gptkbp:environmental_impact |
low
minimal |
| gptkbp:funding |
grants received
|
| gptkbp:future_plans |
3 years
promising |
| https://www.w3.org/2000/01/rdf-schema#label |
WPC-1178
|
| gptkbp:iceClass |
150 °C
350 °C |
| gptkbp:impact |
nausea
|
| gptkbp:is_aimed_at |
bacterial infections
|
| gptkbp:isATypeOf |
123456-78-9
|
| gptkbp:judgingCriteria |
HPLC
|
| gptkbp:market |
not yet available
|
| gptkbp:notableWork |
significant
|
| gptkbp:operational_status |
investigational new drug
|
| gptkbp:origin |
N-(4-(dimethylamino)phenyl)-2-hydroxy-2-(4-methylphenyl)acetamide
|
| gptkbp:patentCitation |
protected by patents
|
| gptkbp:patentExpiration |
2030
|
| gptkbp:patentNumber |
US1234567
|
| gptkbp:patentStatus |
patented
|
| gptkbp:productionLocation |
laboratory scale
|
| gptkbp:publications |
multiple articles published
|
| gptkbp:regulatoryCompliance |
pending
|
| gptkbp:related_to |
gptkb:WPC-1177
|
| gptkbp:releaseYear |
2020
|
| gptkbp:research |
under investigation
active interest |
| gptkbp:research_focus |
antibiotic resistance
related to WPC-1179 |
| gptkbp:route |
oral
|
| gptkbp:safetyFeatures |
handle with care
non-hazardous |
| gptkbp:storage |
store in a cool, dry place
|
| gptkbp:supplyChain |
established
|
| gptkbp:targets |
bacteria
|
| gptkbp:technology |
exploring new formulations
|
| gptkbp:triggerType |
inhibits cell wall synthesis
|
| gptkbp:uses |
pharmaceutical applications
|
| gptkbp:weight |
233.27 g/mol
|